What is the approximate market price of ibrutinib/ibrutinib in 2025?

Ibrutinib is a targeted drug commonly used to treat chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), Waldenstrom's macroglobulinemia (WM), and chronic graft-versus-host disease (cGVHD). Due to its excellent efficacy, the drug has been widely used around the world and has been approved in many countries and regions, including China.

In China, the original drug ibrutinib has been launched and is included in the scope of medical insurance reimbursement, which allows patients to obtain treatment at a more affordable price. Specifically, taking the original drug of ibrutinib - 90 tablets of 140 mg per bottle - as an example, its market price is about 10,000 yuan. Compared with some other cancer drugs, this price is more reasonable, especially with the support of the medical insurance reimbursement policy, the patient's burden is further reduced.

However, in addition to original drugs, patients can also choose overseas generic drugs. These drugs are basically the same in ingredients as the original drugs and are more affordable. For example, the generic drug produced by Yaopin International in Bangladesh has a specification of 112 pills of 140mg per bottle, and the price is about 2,000 yuan. Although the prices of these generic drugs are relatively low, patients still need to ensure the quality of the drugs when choosing them and consult their doctors to determine whether they are suitable for their treatment options. It should be noted that the price of drugs may be adjusted due to exchange rate fluctuations and other factors, and the specific price will vary with market changes.

Generally speaking, the cost of ibrutinib treatment varies depending on the patient's specific condition, medication period, and whether to choose generic drugs. If you choose the original drug and are supported by medical insurance, the annual treatment cost for the patient will be tens of thousands of yuan. By choosing generic drugs, patients' financial pressure can be further alleviated.

Reference materials:https://www.imbruvica.com/